These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 25479337)

  • 1. Omentin functions to attenuate cardiac hypertrophic response.
    Matsuo K; Shibata R; Ohashi K; Kambara T; Uemura Y; Hiramatsu-Ito M; Enomoto T; Yuasa D; Joki Y; Ito M; Hayakawa S; Ogawa H; Kihara S; Murohara T; Ouchi N
    J Mol Cell Cardiol; 2015 Feb; 79():195-202. PubMed ID: 25479337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adipose-derived protein omentin prevents neointimal formation after arterial injury.
    Uemura Y; Shibata R; Kanemura N; Ohashi K; Kambara T; Hiramatsu-Ito M; Enomoto T; Yuasa D; Joki Y; Matsuo K; Ito M; Hayakawa S; Ogawa H; Murohara T; Ouchi N
    FASEB J; 2015 Jan; 29(1):141-51. PubMed ID: 25300621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Omentin prevents myocardial ischemic injury through AMP-activated protein kinase- and Akt-dependent mechanisms.
    Kataoka Y; Shibata R; Ohashi K; Kambara T; Enomoto T; Uemura Y; Ogura Y; Yuasa D; Matsuo K; Nagata T; Oba T; Yasukawa H; Numaguchi Y; Sone T; Murohara T; Ouchi N
    J Am Coll Cardiol; 2014 Jun; 63(24):2722-33. PubMed ID: 24768874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small molecule QF84139 ameliorates cardiac hypertrophy via activating the AMPK signaling pathway.
    Li XX; Zhang P; Yang Y; Wang JJ; Zheng YJ; Tan JL; Liu SY; Yan YM; Zhang YY; Cheng YX; Yang HT
    Acta Pharmacol Sin; 2022 Mar; 43(3):588-601. PubMed ID: 33967278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adiponectin deficiency exacerbates cardiac dysfunction following pressure overload through disruption of an AMPK-dependent angiogenic response.
    Shimano M; Ouchi N; Shibata R; Ohashi K; Pimentel DR; Murohara T; Walsh K
    J Mol Cell Cardiol; 2010 Aug; 49(2):210-20. PubMed ID: 20206634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Irisin alleviates pressure overload-induced cardiac hypertrophy by inducing protective autophagy via mTOR-independent activation of the AMPK-ULK1 pathway.
    Li RL; Wu SS; Wu Y; Wang XX; Chen HY; Xin JJ; Li H; Lan J; Xue KY; Li X; Zhuo CL; Cai YY; He JH; Zhang HY; Tang CS; Wang W; Jiang W
    J Mol Cell Cardiol; 2018 Aug; 121():242-255. PubMed ID: 30053525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Omentin-1 protects against high glucose-induced endothelial dysfunction via the AMPK/PPARδ signaling pathway.
    Liu F; Fang S; Liu X; Li J; Wang X; Cui J; Chen T; Li Z; Yang F; Tian J; Li H; Yin L; Yu B
    Biochem Pharmacol; 2020 Apr; 174():113830. PubMed ID: 32001235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term activation of adenosine monophosphate-activated protein kinase attenuates pressure-overload-induced cardiac hypertrophy.
    Li HL; Yin R; Chen D; Liu D; Wang D; Yang Q; Dong YG
    J Cell Biochem; 2007 Apr; 100(5):1086-99. PubMed ID: 17266062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attenuation of microRNA-16 derepresses the cyclins D1, D2 and E1 to provoke cardiomyocyte hypertrophy.
    Huang S; Zou X; Zhu JN; Fu YH; Lin QX; Liang YY; Deng CY; Kuang SJ; Zhang MZ; Liao YL; Zheng XL; Yu XY; Shan ZX
    J Cell Mol Med; 2015 Mar; 19(3):608-19. PubMed ID: 25583328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The alteration of protein prenylation induces cardiomyocyte hypertrophy through Rheb-mTORC1 signalling and leads to chronic heart failure.
    Xu N; Guan S; Chen Z; Yu Y; Xie J; Pan FY; Zhao NW; Liu L; Yang ZZ; Gao X; Xu B; Li CJ
    J Pathol; 2015 Apr; 235(5):672-85. PubMed ID: 25385233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delphinidin attenuates pathological cardiac hypertrophy via the AMPK/NOX/MAPK signaling pathway.
    Chen Y; Ge Z; Huang S; Zhou L; Zhai C; Chen Y; Hu Q; Cao W; Weng Y; Li Y
    Aging (Albany NY); 2020 Mar; 12(6):5362-5383. PubMed ID: 32209725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-451 exacerbates lipotoxicity in cardiac myocytes and high-fat diet-induced cardiac hypertrophy in mice through suppression of the LKB1/AMPK pathway.
    Kuwabara Y; Horie T; Baba O; Watanabe S; Nishiga M; Usami S; Izuhara M; Nakao T; Nishino T; Otsu K; Kita T; Kimura T; Ono K
    Circ Res; 2015 Jan; 116(2):279-88. PubMed ID: 25362209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adiponectin Upregulates MiR-133a in Cardiac Hypertrophy through AMPK Activation and Reduced ERK1/2 Phosphorylation.
    Li Y; Cai X; Guan Y; Wang L; Wang S; Li Y; Fu Y; Gao X; Su G
    PLoS One; 2016; 11(2):e0148482. PubMed ID: 26845040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exendin-4 attenuates cardiac hypertrophy via AMPK/mTOR signaling pathway activation.
    Zhou Y; He X; Chen Y; Huang Y; Wu L; He J
    Biochem Biophys Res Commun; 2015 Dec 4-11; 468(1-2):394-9. PubMed ID: 26519882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Globular adiponectin inhibits angiotensin II-induced nuclear factor kappaB activation through AMP-activated protein kinase in cardiac hypertrophy.
    Wang C; Li L; Zhang ZG; Fan D; Zhu Y; Wu LL
    J Cell Physiol; 2010 Jan; 222(1):149-55. PubMed ID: 19780028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fat-derived factor omentin stimulates endothelial cell function and ischemia-induced revascularization via endothelial nitric oxide synthase-dependent mechanism.
    Maruyama S; Shibata R; Kikuchi R; Izumiya Y; Rokutanda T; Araki S; Kataoka Y; Ohashi K; Daida H; Kihara S; Ogawa H; Murohara T; Ouchi N
    J Biol Chem; 2012 Jan; 287(1):408-417. PubMed ID: 22081609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carnosol suppresses cardiomyocyte hypertrophy via promoting the activation of AMPK pathway.
    Tian Y; Liu R; Yang Q; Zhang J; Liu Z; Dong B; Gao J; Wan L
    Biochem Biophys Res Commun; 2024 Oct; 729():150343. PubMed ID: 38986259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The TIR/BB-loop mimetic AS-1 prevents cardiac hypertrophy by inhibiting IL-1R-mediated MyD88-dependent signaling.
    Zhu Y; Li T; Song J; Liu C; Hu Y; Que L; Ha T; Kelley J; Chen Q; Li C; Li Y
    Basic Res Cardiol; 2011 Sep; 106(5):787-99. PubMed ID: 21533832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AMPK activation enhances PPARα activity to inhibit cardiac hypertrophy via ERK1/2 MAPK signaling pathway.
    Meng R; Pei Z; Zhang A; Zhou Y; Cai X; Chen B; Liu G; Mai W; Wei J; Dong Y
    Arch Biochem Biophys; 2011 Jul; 511(1-2):1-7. PubMed ID: 21530483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sophoricoside ameliorates cardiac hypertrophy by activating AMPK/mTORC1-mediated autophagy.
    Gao M; Hu F; Hu M; Hu Y; Shi H; Zhao GJ; Jian C; Ji YX; Zhang XJ; She ZG; Li H; Zhu L
    Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 32964914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.